Farringdon Capital »

Intellia Therapeutics shares owned by Farringdon Capital

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Farringdon Capital from 13F filings

Historical chart of Farringdon Capital investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Farringdon Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Farringdon Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $138k 15k 8.99

More positions owned by Farringdon Capital

Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr Trust Ishare 0-1 (SHV)
Ishares Ethereum Tr SHS (ETHA)
Haleon Spon Ads (HLN)
Broadcom (AVGO)
Bitwise Bitcoin Etf Tr Shs Ben Int (BITB)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Vaneck Bitcoin Etf Sh Ben Int (HODL)
Invesco Galaxy Bitcoin Etf Com Shs Ben Int (BTCO)
Zillow Group Cl C Cap Stk (Z)
National Grid Sponsored Adr Ne (NGG)
Alphabet Cap Stk Cl C (GOOG)
Pearson Sponsored Adr (PSO)
Meta Platforms Cl A (META)
HSBC HLDGS Spon Adr New (HSBC)

View all positions for Farringdon Capital

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
State Street Corporation
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
D. E. Shaw & Co
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Two Sigma Advisers
Dimensional Fund Advisors
Susquehanna International
FMR

View all funds holding Intellia Therapeutics